Zusammenfassung
➲ Aufgrund der Lokalisation eines Karzinoms in der Speiseröhre oder im Magen und der damit verbundenen relativ leichten Zugänglichkeit durch endoskopische Diagnostik kommt der Risikobeurteilung einer Karzinomentwicklung sowie den damit verbundenen Möglichkeiten an Vorsorgeuntersuchungen und Prävention eine besondere Bedeutung zu.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Altorki NK, Sunagawa M, Little AG, Skinner DB (1991 ) High-grade dysplasia in the columnar-lined esophagus. Am J Surg 161:97–99
Appelqvist P, Salmo M (1980) Lye corrosion carcinoma of the esophagus. Cancer 45:2655
Arnott SJ, Pearson JG, Finlayson ND, Shearman DJC (1971 ) The association of squamous esophageal cancer an thyroid disease. Br J Cancer 25:33
Attwood SEA, Barlow AP, Norris TL, Watson A (1992) Barrett’s oesophagus:effects of antireflux surgery on symptom control and development of complications. Br J Surg 79:1050–1053
Beresford SAA (1985) Is nitrate in the drinking water associated with the risk of cancer in the urban UK? Int J Epidemiol 14:57
Bloss RS, Miller TA, Copeland EM (1980) Carcinoma of the stomach in the young adult. Surg Gynecol Obstet 150:883
Blot WJ, Devesa SS, Fraumeni Jr JR (1993) Continuing climb in rates of esophageal adenocarcinoma:an update. JAMA 270:1320
Bonavina L, Ceriani C, Carazzone A, Segalin A, Ferrero S, Peracchia A (1999) Endoscopic laser ablation of nondysplastic Barrett’s epithelium: is it worthwhile? Gastrointest Surg 3:194–199
Bosseckert H, Rabbe G (1983) Multiple polyps in the stomach-how many polyps should be ectomized. Endoscopy 15:150
Brand DL, Ylvisaker JT, Gelfand M, Pope CE (1980) Regression of columnar esophagus (Barrett’s) epithelium after antireflux surgery. N Engl J Med 102:844–888
Bremner CG, DeMeester TR (1998) Pathology and pathogenesis of Barrett’s esophagus. In: Proceedings from an international conference on ablation therapy for Barrett’s mucosa. Dis Esophagus 11:1–27
Brown L, Swanson C, Gridley G et al. (1995) Adenocarcinoma of the esophagus. Role of obesity and diet. J Natl Cancer Inst 87:104–109
Cameron AJ, Carpenter HA (1997) Barrett’s Barrett’s esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 92:586–591
Cameron AJ, Lomboy CT, Pera M, Carpenter HA (1995) Adenocarcinoma of the Esophagogastric Junction and Barrett’s Esophagus. Gastroenterology 109:1541–1546
Cameron AJ, Ott BJ, Payne WS (1985) The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med 313:857–859
Chen VW, Abus-Elyazeed RR, Zavala DE et al. (1990) Riskfactors of gastric precancerous lesions in a high-risk Colombian population. Nitrate Nitrite Nutr Cancer 13:67
Chen LQ, Hu CY, Ghadirian P, Duranceau A (1999) Early detection of esophageal squamous cell carinoma and ist effects on therapy:an overview. Dis Esophagus 12:161–167
Chow W, Blot W, Baughan T et al. (1998) Body mass index and riskof adenocarcinoma of the esophagus and gastric cardia.J Natl Cancer Inst 90:150–155
Chow W, Finkle W, McLaughlin J, Frankl H, Ziel H, Fraumeni J (1995) The relation of gastroesophageal reflux disease and its treatment to adenocarcinoma of the esophagus and gastric cardia. JAMA 274: 474–477
Clark GWB, Smyrk TC, Burdiles P et al. (1994) Is Barrett’s metaplasia the source of adenocarcinomas of the cardia? Arch Surg 129:609–614
Coordinating group for research in esophageal cancer-Linhsien County, Honan (1976) Early diagnosis and surgical treatment of esophageal cancer under rural conditions. Chin Med J 2:113
Correa P, Fontham E, Pickle LW et al. (1985) Dietary determinants of gastric cancer in south Louisiana inhabitants. J Natl Cancer Inst 75:645
Cuello C, Correa P, Haenszel W et al. (1976) Gastric cancer in clomba:Cancer risk and suspect environmental agents. J Natl Cancer Inst 537: 1015
DeMeester TR, Attwood SEA, Smyrk TC, Therkildsen DH, Hinder RA (1990) Surgical therapy in Barrett’s esophagus. Ann Surg 212: 528–540
De Meester SR, De Meester TR (2000) Columnar mucosa and intestinal metaplasia of the esophagus. Fifty years of controversy. Ann Surg 231:303–321
Edwards MJ, Gable DR, Lentsch AB, Richardson DJ (1996) The Rationale for Esophagectomy as the optimal therapy for Barrett’s esophagus with high-grade dysplasia. Ann Surg 223:585–591
Eng C, Spechler S, Ruben R, Li F (1993) Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev 2:397–399
Fahmy N, King J (1993) Barrett’s esophagus:an acquired condition with genetic predisposition. Am J Gastroenterol 88:1262–1265
Falk GW, Rice TW, Goldblum JR, Richter JE et al. (1999) Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc 49:170–176
Ferguson MK, Naunheim KS (1997) Resection for Barrett’s mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 114:824–829
Ferraris R, Bonelli L, Conio M, Fracchia M, Lapertosa G, Aste H (1997) Incidence of Barrett’s adenocarcinoma in an Italian population:an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE). Eur J Gastroenterol Hepatol 9 (9): 881–885
Froelicher P, Miller G (1986) The European experience with esophageal cancer limited to the mucosa and submucosa. Gastrointest Endosc 32:88
Gammon M, Schoenberg J, Ahsan H et al. (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89:1277–1284
Graham S, Haughey B, Marshall J et al. (1990) Diet in the epidemiology of gastric cancer. Nutr Cancer 13:19
Grunewald M, Vieth M, Kreibich H, Bethke B, Stolte M (1997) Untersuchungen zum Stand der Diagnostik des Barrett-Ösophagus. Dtsch Med Wochenschr 122:427–431
Guojun H, Lingfang S, Dawei Z et al. (1981 ) Diagnosis and surgical treatment of early esophageal carcinoma. Chin Med J 94:229
Haggit RC, Tryzelaar J, Ellis FH, Colcher H (1978) Adenocarcinoma complicating columnar-epithelium-lined (Barrett’s) esophagus. Am J Clin Pathol 70:1
Hameeteman W, Tytgat GNJ, Houthoff HJ, Van Den Tweel JG (1989) Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96:1249–1256
Hamilton SR, Smith RR (1997) The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett’s esophagus. Am J Clin Pathol 87:301–312
Heitmiller RF, Redmond M, Hamilton SR (1996) Barrett’s esophagus with high-grade dysplasia. An indication for prophylactic esopahgectomy. Ann Surg 224:66–71
Hirota W, Loughney T, Lazas D, Maydonovitch C, Rholl V, Wong R (1999) Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116:277–285
Hölscher A, Gutschow KTE, Schneider P (1998) What is the evolution of Barrett’s mucosa after antireflux surgery? In: Guili R (ed) The esophagogastric junction. OESO, John Libbey Eurotext, Paris: pp 1047–1052
Huang J, Subbaramiah S, Chen Y, Hunt R (1998) Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114:1169–1179
Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M (1993) Lenght of Barrett’s oesophagus:an important factor in the development of dysplasia and adenocarcinoma. Gut 33(9): 1155–1158
Jankowski JA, Wright NA, Meltzer SJ et al. (1999) Molecular Evolution of the metaplasia-Dysplasia-Adenocarinoma Sequence in the Esophagus. Am J Pathol 154:965–973
Jedrychowski W, Wahrendorf J, Popiela T, Rachtan J (1986) A case-control study of dietary factors and stomach cancer risk in Poland. Int J Cancer 37:837
Klinkenberg-Knol EC, Nelis F, Dent J et al. (2000) Long-term Omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 118: 661–669
Knight TM, Forman D, Pirastu R et al. (1990) Nitrate and nitrite exposure in Italian populations with different gastric cancer rates. Int J Epidemiol 19:510
Lagergren J, Bergström R, Lindgren A, Nyrén O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. NE 340:825–831
La Vecchia CL, Liati P, Decarli A et al. (1986) Tar yields of cigarettes and the risk of oesophageal cancer. Int J Cancer 38:381
Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BR (1993) An endoscopic biopsy protocol can differentiate highgrade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 105:40–50
Mecklin JP, Nording S, Sagrio I (1988) Carcinoma of the stomach and its heredity in young patients. Scand J Gastroenterol 23:307
Ming S (1977) The classification and significance of gastric polyps. In: International Academy of Pathology Monograph-the gastrointestinal tract: 149
Murson BC, Sobin LH, Grundmann E et al. (1980) Precancerous condition and epithelial dysplasia in the stomach. J Clin Pathol 33:19
Ortiz A, Martinez de Haro LF, Parilla P et al. (1996) Conservative treatment versus antireflux surgery in Barrett’s oesophagus:long-term results of a prospective study. Br J Surg 83:274–278
Parsonnett J, Friedman G, Vandersteen DP et al. (1991 ) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127–1131
Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR (1993) Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104:510–513
Pera M, Fernandez PL, Pera M etal. (2001 ) Expression of cyclin D1 and p53 and ist correlation with proliferative activity in the spectrum of esophageal carcinomas induced after duodenal content reflux and 2, 6-dimethylnitrosomorpholine administration in rats. Carcinogenesis 22/2:271–277
Pera M, Trastek VF, Carpentier HA, Allen MS, Deschamps C, Pairolero PC (1992) Barrett’s esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 54:199–204
Peters JH, Clark G, Ireland A et al. (1994) Ooutcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and non-surveyed patients. J Thorac Cardiovasc Surg 108:813–822
Rice TW, Falk GW, Achkar E, Petras RE (1993) Surgical management of high-grade dysplasia in Berrett’s esophagus. Am J Gastroenterol 88:1832–1836
Risch HA, Jain M, Choi NW et al. (1985) Dietary factors and the incidence of cancer of the stomach. Am J Epidemiol 122:947
Romero Y, Cameron A, Locke R et al. (1997) Familial aggregation of gastroesphageal reflux in patients with Barrett’s esophagus and esophageal adenocarinoma. Gastroenterlogy 113:1449–1456
Sagar PM, Ackroyd R, Hosie KB et al. (1995) Regression and progression of Barrett’s esophagus after antireflux surgery. Br J Surg 82:806–810
Sampliner RE, Faigel D, Fennerty MB et al. (2001 ) Effective and safe endoscopic reversal of nondysplastic Barrett’s esophagus with high-dose acid inhibition: a multicenter study. Gastrointest Endoscopy 53:554–558
Sandler RS, Johnson MD, Holland KL (1984) Risk of stomach cancer after gastric surgery for benign conditions. A case-control study. Dig Dis Sci 29:703
Schnell TG, Sonntag SJ, Chejfec A (1992) Adenocarcinomas arising in tongues or short segments of Barrett’s esophagaus. Dig Dis 37: 137–143
Schwindt WD, Berhardt LC, Johnson SA (1970) Tylosis and intrathoracic neoplasms. Chest 57:590
Spechler SJ, Goyal RK (1986) Barrett’s esophagus. N Engl J Med 315: 362–371
Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK (1994) Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 344:1533–1536
Stalnikowicz R, Benbassat J (1990) Risk of gastric cancer after gastric surgery for benign disorders. Arch Int Med 150:2022
Streitz JM, Andrews CW, Ellis FH (1993) Endoscopic surveillance of Barrett’s esophagus. Does it help? J Thorac Cardiovasc Surg 105: 383–387
The EUROGAST Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341: 1359–1362
Tigges H, Fuchs KH, Maroske J et al. (2001 ) Combination of endoscopic Argon plasma coagulation and antireflux surgery for treatment of Barrett’s esophagus. J Gastrointest Surg 5:251–259
Trichopoulos D, Ourano G, Day NE et al. (1985) Diet and cancer of the stomach: a case-control study in Greece. Int J Cancer 36:291
Tsuji Nishiguro S, Mano M et al. (2000) Time trends for small gastric cancer in Japan. Gastric Cancer 3:123–127
Van der Veen AH, Dees J, Blankenstein JD, Van Blankenstein M (1989) Adenocarcinoma in Barrett’s oesophagus:an overrated risk. Gut 30 (1): 14–18
Viste A, Bjornestad E, Opheim D et al. (1986) Risk of carcinoma following gastric operations for benign disease. Lancet II: 502
Wienbeck M, Berges W (1981) Oesophageal lesions in the alcoholic. Clin Gastroenterol 10:375
Williamson WA, Ellis HF, Gibb SP, Shahian DM, Aretz HT (1990) Effect of antireflux operation on Barrett’s mucosa. Ann Thorac Surg 49: 537–542
Williamson WA, Ellis HF, Gibb SP et al. (1991) Barrett’s esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 151: 2212–2216
Wynder EL, Reddy BS, McCoy GD, Weisberg JH, Williams GM (1976) Diet and gastrointestinal cancer. Gastroenterology 5:463
Zhang Z, Kurtz R, Yu G et al. (1997) Adenocarcinomas of the esophagus and gastric cardia:the role of diet. Nutrition Cancer 27:298–309
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fuchs, K.H. (2004). Risiko, Prävention und Vorsorgeuntersuchungen. In: Management des Magen- und Ösophaguskarzinoms. Onkologie aktuell. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18700-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-18700-1_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62254-0
Online ISBN: 978-3-642-18700-1
eBook Packages: Springer Book Archive